| Contents |
|
| Description | EN PROSTA™ is an advanced bioregulatory peptide formulation containing Prostamax, designed to support prostate health, urinary wellness, and overall male vitality. Prostamax is a peptide-based compound studied for its role in maintaining healthy prostate tissue function and supporting age-related changes associated with male reproductive wellness. By promoting cellular regulation and tissue homeostasis within the prostate, EN PROSTA™ may help support normal prostate function, healthy urinary flow, and balanced inflammatory responses. It contributes to maintaining optimal cellular health, connective tissue integrity, and physiological balance as part of a comprehensive men's wellness approach. EN PROSTA™ may be used in protocols focused on healthy ageing, prostate wellness, hormonal balance, and maintaining overall male vitality. |
| Administration | Administer via Subcutaneous (SC) injection under the supervision of a qualified healthcare professional. |
| Storage |
|
| Dosage | Typical dosage: 500–1000 mcg per day. Dosage may be adjusted according to individual requirements, response, and professional guidance. Use under medical supervision. |
| Indication | EN PROSTA™ may be used in:
|
| Contraindications | Do not use EN PROSTA™ if:
|
| Special Precautions |
|
| Adverse Drug Reactions |
|
| Drug Interactions | Limited interaction data are available. Use cautiously with:
|
| Disclaimer | Images shown on the website are for representation purposes only and may differ from the actual product. Packaging designs may change without prior notice. Use only under professional medical supervision. |